Benzinga | Dec 20, 2021 07:35AM EST

Credit Suisse Maintains Outperform on Medtronic, Lowers Price Target to $142

Credit Suisse analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $146 to $142.